Skip to content
Back to glossary
Immune system

Clonal hematopoiesis (CHIP)

DEKlonale Hämatopoese (CHIP)

Clonal hematopoiesis of indeterminate potential (CHIP) means one blood stem cell, carrying a driver mutation, has quietly expanded into a large clone. The usual mutated genes are DNMT3A, TET2, ASXL1, or JAK2. It happens in people with no blood cancer. It gets much more common with age, reaching about 10 to 20% in people over 70. Landmark work by Jaiswal and colleagues (2017) showed that CHIP carriers have about double the risk of heart events. Part of the reason: TET2-mutant clones push immune cells (macrophages) toward inflammation. CHIP also rewires how blood cells switch genes on and off. So it can throw off DNA-methylation age clocks and other blood-based aging markers. That makes it an important caveat when you read those results.

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. Jaiswal S, Natarajan P, Silver AJ, et al.. (2017). Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. *New England Journal of Medicine*doi:10.1056/NEJMoa1701719
  2. Holstege H, Pfeiffer W, Sie D, et al.. (2014). Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. *Genome Research*doi:10.1101/gr.162131.113

Related studies from the research library